Literature DB >> 20967422

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.

W D Leslie1, C Berger, L Langsetmo, L M Lix, J D Adachi, D A Hanley, G Ioannidis, R G Josse, C S Kovacs, T Towheed, S Kaiser, W P Olszynski, J C Prior, S Jamal, N Kreiger, D Goltzman.   

Abstract

UNLABELLED: A procedure for creating a simplified version of fracture risk assessment tool (FRAX®) is described. Calibration, fracture prediction, and concordance were compared with the full FRAX tool using two large, complementary Canadian datasets.
INTRODUCTION: The Canadian Association of Radiologists and Osteoporosis Canada (CAROC) system for fracture risk assessment is based upon sex, age, bone mineral density (BMD), prior fragility fracture, and glucocorticoid use. CAROC does not require computer or web access, and categorizes 10-year major osteoporotic fracture risk as low (<10%), moderate (10-20%), or high (>20%).
METHODS: Basal CAROC fracture risk tables (by age, sex, and femoral neck BMD) were constructed from Canadian FRAX probabilities for major osteoporotic fractures (adjusted for prevalent clinical risk factors). We assessed categorization and fracture prediction with the updated CAROC system in the CaMos and Manitoba BMD cohorts.
RESULTS: The new CAROC system demonstrated high concordance with the Canadian FRAX tool for risk category in both the CaMos and Manitoba cohorts (89% and 88%). Ten-year fracture outcomes in CaMos and Manitoba BMD cohorts showed good discrimination and calibration for both CAROC (6.1-6.5% in low-risk, 13.5-14.6% in moderate-risk, and 22.3-29.1% in high-risk individuals) and FRAX (6.1-6.6% in low-risk, 14.4-16.1% in moderate-risk, and 23.4-31.0% in high-risk individuals). Reclassification from the CAROC risk category to a different risk category under FRAX occurred in <5% for low-risk, 20-24% for moderate-risk, and 27-30% for high-risk individuals. Reclassified individuals had 10-year fracture outcomes that were still within or close to the original nominal-risk range..
CONCLUSION: The new CAROC system is well calibrated to the Canadian population and shows a high degree of concordance with the Canadian FRAX tool. The CAROC system provides s a simple alternative when it is not feasible to use the full Canadian FRAX tool.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20967422      PMCID: PMC5104542          DOI: 10.1007/s00198-010-1445-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  34 in total

1.  Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system.

Authors:  N P Roos; E Shapiro
Journal:  Med Care       Date:  1999-06       Impact factor: 2.983

Review 2.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

3.  Validation of an electronic, population-based prescription database.

Authors:  A L Kozyrskyj; C A Mustard
Journal:  Ann Pharmacother       Date:  1998-11       Impact factor: 3.154

4.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Authors:  L-A Fraser; L Langsetmo; C Berger; G Ioannidis; D Goltzman; J D Adachi; A Papaioannou; R Josse; C S Kovacs; W P Olszynski; T Towheed; D A Hanley; S M Kaiser; J Prior; S Jamal; N Kreiger; J P Brown; H Johansson; A Oden; E McCloskey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2010-12-16       Impact factor: 4.507

5.  Simplified system for absolute fracture risk assessment: clinical validation in Canadian women.

Authors:  William D Leslie; James F Tsang; Lisa M Lix
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

6.  The importance of spectrum bias on bone density monitoring in clinical practice.

Authors:  William D Leslie
Journal:  Bone       Date:  2006-03-13       Impact factor: 4.398

7.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

8.  International variations in hip fracture probabilities: implications for risk assessment.

Authors:  John A Kanis; Olof Johnell; Chris De Laet; Bengt Jonsson; Anders Oden; Alan K Ogelsby
Journal:  J Bone Miner Res       Date:  2002-07       Impact factor: 6.741

9.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

10.  Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD.

Authors:  Lisa Langsetmo; David Goltzman; Christopher S Kovacs; Jonathan D Adachi; David A Hanley; Nancy Kreiger; Robert Josse; Alexandra Papaioannou; Wojciech P Olszynski; Sophie A Jamal
Journal:  J Bone Miner Res       Date:  2009-09       Impact factor: 6.741

View more
  46 in total

1.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

2.  Recommendations for preventing fracture in long-term care.

Authors:  Alexandra Papaioannou; Nancy Santesso; Suzanne N Morin; Sidney Feldman; Jonathan D Adachi; Richard Crilly; Lora M Giangregorio; Susan Jaglal; Robert G Josse; Sharon Kaasalainen; Paul Katz; Andrea Moser; Laura Pickard; Hope Weiler; Susan Whiting; Carly J Skidmore; Angela M Cheung
Journal:  CMAJ       Date:  2015-09-14       Impact factor: 8.262

Review 3.  Assessment of fracture risk.

Authors:  Sanford Baim; William D Leslie
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

4.  Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.

Authors:  Rasheeda K Hall; Richard Sloane; Carl Pieper; Courtney Van Houtven; Joanne LaFleur; Robert Adler; Cathleen Colón-Emeric
Journal:  J Am Geriatr Soc       Date:  2018-01-10       Impact factor: 5.562

5.  A comparative study of using non-hip bone density inputs with FRAX®.

Authors:  W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2011-10-19       Impact factor: 4.507

6.  A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy.

Authors:  C E Lee; W D Leslie; P Czaykowski; J Gingerich; M Geirnaert; Y K J Lau
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

7.  Ankle fractures do not predict osteoporotic fractures in women with or without diabetes.

Authors:  J M Pritchard; L M Giangregorio; G Ioannidis; A Papaioannou; J D Adachi; W D Leslie
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

8.  Competing mortality and fracture risk assessment.

Authors:  W D Leslie; L M Lix; X Wu
Journal:  Osteoporos Int       Date:  2012-06-27       Impact factor: 4.507

9.  Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos).

Authors:  George Ioannidis; Shelley Pallan; Alexandra Papaioannou; Manisha Mulgund; Lorena Rios; Jinhui Ma; Lehana Thabane; Kenneth S Davison; Robert G Josse; Christopher S Kovacs; Nancy Kreiger; Wojciech P Olszynski; Jerilynn C Prior; Tanveer Towheed; Jonathan D Adachi
Journal:  Arch Osteoporos       Date:  2014-02-28       Impact factor: 2.617

Review 10.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.